Evidence map›Paper›PMID 35424452›Full record

ArticleRSC advances2021

Immunoassay-aptasensor for the determination of tumor-derived exosomes based on the combination of magnetic nanoparticles and hybridization chain reaction.

Hua Zhang, Yajuan Zhou, Dan Luo, Jingjian Liu, E Yang, Guangyi Yang, Guangjun Feng, Qinhua Chen, Lun Wu

Erratum issuedAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. [Advances in exosome-targeting aptamer-screening techniques].Se pu = Chinese journal of chromatography · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Aptasensors versus immunosensors-Which will prevail?Engineering in life sciences · 2022
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hua ZhangAffiliated Dongfeng Hospital, Hubei University of Medicine Shiyan 442008 Hubei China wulun0909@163.com.
Yajuan ZhouDepartment of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430074 China.
Dan LuoAffiliated Dongfeng Hospital, Hubei University of Medicine Shiyan 442008 Hubei China wulun0909@163.com.
Jingjian LiuAffiliated Dongfeng Hospital, Hubei University of Medicine Shiyan 442008 Hubei China wulun0909@163.com.
E YangShenzhen Baoan Authentic TCM Therapy Hospital Shenzhen Guangdong 518101 China cqh77@163.com + 86-0719-8272238.
Guangyi YangShenzhen Baoan Authentic TCM Therapy Hospital Shenzhen Guangdong 518101 China cqh77@163.com + 86-0719-8272238.
Guangjun FengShenzhen Baoan Authentic TCM Therapy Hospital Shenzhen Guangdong 518101 China cqh77@163.com + 86-0719-8272238.
Qinhua ChenShenzhen Baoan Authentic TCM Therapy Hospital Shenzhen Guangdong 518101 China cqh77@163.com + 86-0719-8272238.ORCID https://orcid.org/0000-0002-9108-1314
Lun WuAffiliated Dongfeng Hospital, Hubei University of Medicine Shiyan 442008 Hubei China wulun0909@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of tumor-related exosomes is of great significance. In this work, a fluorescence aptasensor was designed for the determination of tumor-related exosomes based on the capture of magnetic nanoparticles (MNPs) and specific recognition of an aptamer. MNPs were used as substrates to capture the exosomes by modifying the CD63 antibody on the MNP surface. Probe 1 consists of PDL-1 aptamer sequence and a section of other sequences. PDL-1 expression was observed on the surface of exosomes; the aptamer of PDL-1 could combine with PDL-1 with high affinity. Thus, the immunoassay-type compounds of "MNPs-exosomes-probe 1" were formed. The other section of probe 1 triggered the HCR with probe 2 and probe 3 and formed the super-long dsDNA. The addition of GelRed resulted in the generation of an amplified fluorescence signal. The proposed design demonstrated a good linearity with the exosome concentration ranging from 300 to 10

Identifiers

PMID35424452
PMCPMC8694620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.